Smart lock maker Level faces an uncertain future after parent company Assa Abloy reportedly laid off most of its staff, ...

Metabolic reprogramming is the hallmark of malignant tumors. Both metabolic phenotype and metabolic dependence are changed during the development of cancer from precancerous tissue to local invasion ...

According to the source, Assa Abloy, a Sweden-based multinational company that purchased Level Home in 2024, is transferring ...

Kwikset predates smart lock technology and has been in the business of making locks for around 80 years. Has that long history allowed them to create the best smart locks? Or, would you be better off ...

In oncology, the manipulation of metabolic processes within tumors has surfaced as a pivotal strategy for influencing cancer progression and therapy resistance. Tumor cells often undergo metabolic ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...